Product Description
Product Name: Velpanat Tablet
Composition: Sofosbuvir 400 mg + Velpatasvir 100 mg
Form: Oral Tablet
Category: Antiviral / Direct-Acting Antiviral (DAA)
Indication: Chronic Hepatitis C Virus (HCV) Infection
Velpanat Tablet is a fixed-dose combination antiviral medication used for the treatment of chronic hepatitis C virus (HCV) infection across all six genotypes (genotype 1–6). It contains Sofosbuvir, a nucleotide polymerase inhibitor, and Velpatasvir, an NS5A inhibitor. Together, they target and inhibit multiple steps in the HCV replication process, leading to effective viral suppression and clearance.
